Skip to content
Study details
Enrolling now

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis

University of Kansas Medical Center
NCT IDNCT06428006ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

70

Study length

about 2.8 years

Ages

18–65

Locations

1 site in KS

About this study

Researchers are testing whether cognitive behavioral therapy for insomnia (CBT-I) can help people with multiple sclerosis improve their sleep and overall well-being. The trial will compare CBT-I to a control group, and also look at what factors might make some people more likely to benefit from the treatment.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Cognitive behavioral therapy for insomnia
  • 2.Participate in Sleep and lifestyle education
PhasePhase 2
Primary goalInsomnia Severity Index (ISI)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low8%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Insomnia Severity Index (ISI)

Secondary: Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), Pittsburgh Sleep Quality Index (PSQI)

Procedures

therapy

Body systems

Neurology